TrialInternational journal of clinical oncology2026

Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer.

Hsiu-Tzu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.